ATE378408T1 - Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren - Google Patents
Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetierenInfo
- Publication number
- ATE378408T1 ATE378408T1 AT99969114T AT99969114T ATE378408T1 AT E378408 T1 ATE378408 T1 AT E378408T1 AT 99969114 T AT99969114 T AT 99969114T AT 99969114 T AT99969114 T AT 99969114T AT E378408 T1 ATE378408 T1 AT E378408T1
- Authority
- AT
- Austria
- Prior art keywords
- seq
- ztgfss9
- mammal
- growth factor
- transforming growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15481798A | 1998-09-17 | 1998-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE378408T1 true ATE378408T1 (de) | 2007-11-15 |
Family
ID=22552920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99969114T ATE378408T1 (de) | 1998-09-17 | 1999-09-17 | Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1897948A1 (de) |
JP (2) | JP2002525056A (de) |
AT (1) | ATE378408T1 (de) |
AU (1) | AU6050499A (de) |
CA (2) | CA2706859A1 (de) |
DE (1) | DE69937570T2 (de) |
DK (1) | DK1114156T3 (de) |
ES (1) | ES2300154T3 (de) |
IL (1) | IL141869A0 (de) |
WO (1) | WO2000015798A2 (de) |
ZA (1) | ZA200101819B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999060127A2 (en) | 1998-05-15 | 1999-11-25 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
US6562578B1 (en) | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
EP1443055A3 (de) * | 1998-05-29 | 2005-06-08 | Human Genome Sciences, Inc. | Interleukine-21 und 22 |
IL143600A0 (en) * | 1999-01-11 | 2002-04-21 | Schering Corp | Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses |
EP2290081A3 (de) * | 1999-12-23 | 2012-08-01 | Genentech, Inc. | IL-17-homologe Polypeptide und ihre therapeutische Verwendung |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
US20030166268A1 (en) * | 2000-05-31 | 2003-09-04 | Holloway James L. | Mammalian transforming growth factor beta-10 |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2002044379A2 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
EP1359938B1 (de) | 2001-01-25 | 2011-03-16 | ZymoGenetics, Inc. | Verfahren zur behandlung von psoriasis unter verwendung eines il-17d antagonisten |
AU2002318513A1 (en) * | 2001-07-06 | 2003-01-21 | Nsgene A/S | Novel neurotrophic factors |
GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
WO2008058251A1 (en) * | 2006-11-08 | 2008-05-15 | Zymogenetics, Inc. | Variants and methods of using transforming growth factor beta-9 |
US20090317400A1 (en) | 2008-05-05 | 2009-12-24 | Krzysztof Masternak | Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
MX2011011729A (es) | 2009-05-05 | 2012-04-10 | Novimmune Sa | Anticuerpo anti il-17f y metodos de uso de los mismos. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532159A (en) * | 1994-04-01 | 1996-07-02 | The Ohio State University | Monoclonal antibody to canine placental oncofetal protein for detecting cancer |
DK0839196T3 (da) * | 1995-07-19 | 2005-09-12 | Inst Genetics Llc | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner |
ES2223127T3 (es) * | 1997-04-25 | 2005-02-16 | Zymogenetics, Inc. | Factor 7 mamario del tipo citoquina. |
US20030003545A1 (en) | 1998-05-29 | 2003-01-02 | Reinhard Ebner | Interleukins-21 and 22 |
IL143600A0 (en) | 1999-01-11 | 2002-04-21 | Schering Corp | Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses |
-
1999
- 1999-09-17 EP EP07017934A patent/EP1897948A1/de not_active Withdrawn
- 1999-09-17 CA CA2706859A patent/CA2706859A1/en not_active Abandoned
- 1999-09-17 ES ES99969114T patent/ES2300154T3/es not_active Expired - Lifetime
- 1999-09-17 DE DE69937570T patent/DE69937570T2/de not_active Expired - Lifetime
- 1999-09-17 IL IL14186999A patent/IL141869A0/xx unknown
- 1999-09-17 DK DK99969114T patent/DK1114156T3/da active
- 1999-09-17 WO PCT/US1999/021677 patent/WO2000015798A2/en active IP Right Grant
- 1999-09-17 EP EP99969114A patent/EP1114156B1/de not_active Expired - Lifetime
- 1999-09-17 AT AT99969114T patent/ATE378408T1/de active
- 1999-09-17 JP JP2000570325A patent/JP2002525056A/ja not_active Withdrawn
- 1999-09-17 AU AU60504/99A patent/AU6050499A/en not_active Abandoned
- 1999-09-17 CA CA2343569A patent/CA2343569C/en not_active Expired - Fee Related
-
2001
- 2001-03-05 ZA ZA200101819A patent/ZA200101819B/en unknown
-
2010
- 2010-04-22 JP JP2010098890A patent/JP2010187691A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2343569C (en) | 2010-09-14 |
DE69937570D1 (de) | 2007-12-27 |
AU6050499A (en) | 2000-04-03 |
JP2010187691A (ja) | 2010-09-02 |
EP1114156A2 (de) | 2001-07-11 |
IL141869A0 (en) | 2002-03-10 |
DE69937570T2 (de) | 2009-04-23 |
WO2000015798A2 (en) | 2000-03-23 |
WO2000015798A3 (en) | 2000-05-25 |
DK1114156T3 (da) | 2008-03-03 |
CA2343569A1 (en) | 2000-03-23 |
ZA200101819B (en) | 2001-09-27 |
ES2300154T3 (es) | 2008-06-01 |
CA2706859A1 (en) | 2000-03-23 |
EP1114156B1 (de) | 2007-11-14 |
EP1897948A1 (de) | 2008-03-12 |
JP2002525056A (ja) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE378408T1 (de) | Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren | |
DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
IL210455A0 (en) | Novel cytokine zcytor17 ligand | |
ATE269902T1 (de) | Cytokinähnliches polypeptid-10 aus säugetieren | |
DK1294888T3 (da) | Interferonlignende protein Zcyto21 | |
HK1078093A1 (en) | Antibodies against fibroblast growth factor 23 | |
ATE536409T1 (de) | Unkrautbekämpfungsstoffwechselproteine, gene dafür und ihre verwendung | |
EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
CY1111763T1 (el) | ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51 | |
DE69929454D1 (de) | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen | |
DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
EA200100440A1 (ru) | Ген prv-1 и его применение | |
EP1295943A4 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
NZ606260A (en) | Novel polypeptides involved in immune response |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1114156 Country of ref document: EP |